Aug. 18 at 12:29 PM
$GLSI So approx. 12 weeks until Bio Europe and then approx. 12 weeks to end of lock up in January. I can't see many people selling before open label update in mid-Sept (4 to 5 weeks from now). In the remaining 7 to 8 weeks between open label update and Bio Europe, we are likely to get screening / enrollment updates, FDA approval on 2nd mfg lot, additional countries / sites added and maybe even interim analysis timing.....so probably not much selling in Sept/Oct as company puts its best foot forward in advance of Bio. When Bio Europe starts, we may get parntership announcement in conjunction with show. If not, we likely have a scenario where multiple suitors are interesting in partnering, so maybe the negotations continue for 8 to 12 weeks after the show, so likely little selling during this stretch either. By then, we should have more clarity and buying / selling will be based on a whole different set of info. IMHO, better act fast if you don't want a much more expensive entry.
